These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38258081)

  • 1. Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections.
    Qiao L; Zhang Y; Chen Y; Chi X; Ding J; Zhang H; Han Y; Zhang B; Jiang J; Lin Y
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria.
    Wang Y; Feng J; Yu J; Wen L; Chen L; An H; Xiao W; Zhang B; Feng H; Zhou M; Jiang Z
    Ann Clin Microbiol Antimicrob; 2024 Jul; 23(1):60. PubMed ID: 38965559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B adjuvants against polymyxin B- and carbapenem-resistant Gram-negative bacteria.
    Salvaterra Pasquini JP; Queiroz PA; Rodrigues do Amaral PH; da Silva TC; Souza Bonfim Mendonça P; Vandresen F; Carvalho Ceolis JP; de Lima Scodro RB; Caleffi-Ferracioli KR; Cardoso RF; Dias Siqueira VL
    Future Microbiol; 2024; 19(17):1445-1454. PubMed ID: 39258398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in vitro synergy of polymyxin B-based combinations against polymyxin B -resistant gram-negative bacilli.
    Li Y; Guo S; Li X; Yu Y; Yan B; Tian M; Xu B; Hu H
    Microb Pathog; 2022 May; 166():105517. PubMed ID: 35398467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IS
    Maybin M; Ranade AM; Schombel U; Gisch N; Mamat U; Meredith TC
    mBio; 2024 Jul; 15(7):e0063424. PubMed ID: 38904391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparative Study of the Microbiological Efficacy of Polymyxin B on Different Carbapenem-Resistant Gram-Negative Bacteria Infections.
    Lu Q; Zhu HH; Li GH; Qi TT; Ye LJ; Teng XQ; Qu Q; He GF; Qu J
    Front Med (Lausanne); 2021; 8():620885. PubMed ID: 33634151
    [No Abstract]   [Full Text] [Related]  

  • 7. Nitazoxanide synergizes polymyxin B against
    Jiang X; Chen D; Wang X; Wang C; Zheng H; Ye W; Zhou W; Liu G; Zhang K
    Microbiol Spectr; 2024 Aug; 12(8):e0019124. PubMed ID: 38904380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective observational study of the treatment with polymyxin B for liver transplantation recipients infected by multidrug-resistant gram-negative bacteria.
    Yu LL; Shi XP; Huang JF; Gong Y; Cui CX; Wang T
    J Clin Pharm Ther; 2022 Oct; 47(10):1563-1569. PubMed ID: 35670240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin B-Based Regimens for Patients Infected with Carbapenem-Resistant Gram-Negative Bacteria: Clinical and Microbiological Efficacy, Mortality, and Safety.
    Qu J; Qi TT; Qu Q; Long WM; Chen Y; Luo Y; Wang Y
    Infect Drug Resist; 2022; 15():1205-1218. PubMed ID: 35345474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacterial infections: a real-world multicenter study.
    Zhang X; Qi S; Duan X; Han B; Zhang S; Liu S; Wang H; Zhang H; Sun T
    J Transl Med; 2021 Oct; 19(1):431. PubMed ID: 34656132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections-A Cohort Study.
    Cai Y; Leck H; Tan RW; Teo JQ; Lim TP; Lee W; Chlebicki MP; Kwa AL
    Antibiotics (Basel); 2020 Jul; 9(8):. PubMed ID: 32726974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyxin B-Modified Fosfomycin Liposomes Target Gram-Negative Bacteria and Exert Synergistic Antibacterial Effect.
    Zhu R; Yin Z; Liu N; Wang Z; Zhang H; Li J; Shen L; Zheng A
    ACS Omega; 2023 Dec; 8(48):45914-45923. PubMed ID: 38075817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant
    Sturaro MC; Damaceno NdS; Faccin ID; Silva ON; de Aquino TM; Freire NML; Alcântara MGdS; Monteiro KLC; Rossato L; de Souza GHdA; Simionatto S
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0093024. PubMed ID: 39254296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel decoy strategy for polymyxin resistance in
    Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W
    Elife; 2021 Jun; 10():. PubMed ID: 34180396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia.
    Ding P; Li H; Nan Y; Liu C; Wang G; Cai H; Yu W
    Int J Antimicrob Agents; 2024 Oct; 64(4):107293. PubMed ID: 39094752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of polymyxin B combined with cefepime-avibactam against the biofilms of polymyxin B-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae in in vitro and in vivo models.
    Tian M; Yan B; Jiang R; Liu C; Li Y; Xu B; Guo S; Li X
    BMC Microbiol; 2024 Oct; 24(1):409. PubMed ID: 39407114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsis.
    Wang P; Xie C; Zhang Y; Li H; Lu Y; Sun L; Hu X; Nie T; Li C; Li G; Lu X; Pang J; Yang X; Yu L; Li X; Wang X; You X
    Acta Biomater; 2024 Aug; 184():323-334. PubMed ID: 38901753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria.
    Coya JM; Fraile-Ágreda V; de Tapia L; García-Fojeda B; Sáenz A; Bengoechea JA; Kronqvist N; Johansson J; Casals C
    Front Immunol; 2022; 13():927017. PubMed ID: 36159837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study.
    Shinohara DR; Menegucci TC; Fedrigo NH; Migliorini LB; Carrara-Marroni FE; Maria Dos Anjos M; Cardoso CL; Nishiyama SAB; Tognim MCB
    J Med Microbiol; 2019 Mar; 68(3):309-315. PubMed ID: 30663954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.